The U.S. dermatology devices market size is anticipated to reach USD 12.73 billion by 2030 and is projected to grow at a CAGR of 12.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Technological advancements in dermatology devices and the rising prevalence of skin disorders are some of the factors driving the market growth. According to the American Academy of Dermatology Association, acne, and similar skin conditions affect over 50 million people in the U.S. annually.
Highly developed light therapy devices, microdermabrasion devices, and laser devices help dermatology professionals deliver less invasive and more effective treatments. Manufacturers are focusing on developing and launching innovative medical devices for treating skin conditions. For instance, Cytrellis, Inc., a developer and manufacturer of aesthetic medical devices, received its FDA approval in July 2022 for its product Ellacor, which uses tissue micro-coring to deliver skin treatments that are less painful and non-scarring, among other benefits.
Growing awareness regarding early diagnosis and treatment of skin disorders has contributed to the market growth. In addition, according to the Bureau of Economic Analysis, disposable personal income in the U.S. increased by USD 67.6 billion, and personal consumption expenditure increased by USD 43.9 billion in January 2024. As disposable income rises, expenditure on non-essential skin treatments, such as skin tightening and skin resurfacing, among others, is anticipated to increase and boost the market growth.
The American Society of Plastic Surgeons uncovered, based on a poll, that more than 75% of plastic surgery practices gained more business after the pandemic, with approximately 30% of practitioners reporting a 100% increase in business. According to a Forbes Health-Ipsos survey, the pandemic increased negative notions of body image among individuals, which has been increasing the demand for dermatology services.
Request a free sample copy or view report summary: U.S. Dermatology Devices Market Report
The treatment devices segment led the market with the largest revenue share of 79.5% in 2023, owing to the broad applicability of treatment devices. Moreover, the increasing demand for procedures such as tattoo removal is a notable factor fueling the demand for dermatology treatment devices
Based on application, the treatment segment accounted the market with the largest revenue share in 2023 and is projected to grow at the fastest CAGR over the forecast period, owing to rising demand for skin treatments and growing awareness regarding skin care
Based on end-use, the hospitals segment held a majority share in 2023, due to the availability of a wide range of skin treatment options
The clinics segment is projected to grow at the fastest CAGR during the forecast period, owing to the benefit of shorter waiting periods and a large number of clinics present across the nation
Grand View Research has segmented the U.S. dermatology devices market report based on product, application, end-use, and region:
U.S. Dermatology Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
Diagnostic Devices
Dermatoscopes
Microscopes
Other Imaging Devices
Biospy Devices
Treatment Devices
Light Therapy Devices
Lasers
Electrosurgical Equipment
Liposuction Devices
Microdermabrasion Devices
Cryotherapy Devices
U.S. Dermatology Devices Application Outlook (Revenue, USD Million, 2018 - 2030)
Diagnostics Application
Skin Cancer Diagnosis
Other
Treatment Application
Hair Removal
Skin Rejuvenation
Acne, Psoriasis and Tattoo Removal
Wrinkle Removal and Skin Resurfacing
Body Contouring and Fat Removal
Cellulite Reduction
Vascular and Pigmented Lesion Removal
Others
U.S. Dermatology Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Clinics
Others
U.S. Dermatology Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
West
Midwest
Northeast
Southwest
Southeast
List of Key Players in the U.S. Dermatology Devices Market
Cutera, Inc.
Genesis Biosystems, Inc.
Cytrellis, Inc.
Candela Medical Corporation
Bausch Health Companies Inc.
DermLite.
Cynosure Inc.
Avita Medical, Inc,
Skin Science Solutions, Inc.
Canfield Scientific, Inc.
"The quality of research they have done for us has been excellent..."